You are here: Home

SURVMARK-2 will produce high impact cancer survival, incidence and mortality comparisons as part of the International Cancer Benchmarking Partnership (ICBP). The ICBP is a unique and innovative collaboration that brings together clinicians, policy-makers, researchers, and cancer data experts. It aims to measure international differences in cancer survival, and crucially, to identify factors that might be driving these differences.

The SURVMARK-2 project was launched in July 2016 and is set to be completed in early 2020.


As part of the Summer School on Modern Methods in Biostatistics and Epidemiology, Paul Dickman and Paul Lambert will present an intensive 1-week course on the principles, methods and application of statistical methods in population-based cancer survival analysis. Further details are available here - December 2017
A SURVMARK-2 Meeting was organized during the 39th Annual Conference of the International Association of Cancer Registries on 18 October 2017 with SURVMARK-2 colleagues and partners present during the conference.
Call for expertise transfer fellowship applications will soon be launched
Kick-off meeting of the executive group held in London on 27/28 March 2017. View photo
SURVMARK-2 call for data launched in July 2016 – 20 jurisdictions from 6 countries participating